1. Investment Snapshot
2. Thesis
3. Valuation & Price Target
4. Business & Product Moat
5. People & Governance
6. Market & Macro
7. Financial Quality
8. Risk Register
9. Prediction Market
10. 𝕏 Posts
Discussion
Loading...
Loading...
1. Investment Snapshot
2. Thesis
3. Valuation & Price Target
4. Business & Product Moat
5. People & Governance
6. Market & Macro
7. Financial Quality
8. Risk Register
9. Prediction Market
10. 𝕏 Posts
Discussion
1. Investment Snapshot
2. Capital Structure
3. Valuation
Discussion
Symbol
GENB
Event Date
2026-02-27
Sector
Health Care
Subsector
Pharmaceuticals
Offer Range
—
Shares Offered
3.75M
Shares Outstanding Pre-IPO
103.93M
103.93M
—
Implied Upside vs Midpoint
$00.00Description
—
Post-IPO economic shares by class.
| Class | Shares | % Economic |
|---|---|---|
Common Stock (listed) 1 vote per share (standard common) | 102.45M | 98.6% |
ESPP - reserved | 1.48M | 1.4% |
| Total economic shares | 103.93M | 100% |
Outstanding Stock Options (2019 Plan) Unexercised options / warrants | 20.42M |
Options granted after 12/31/2025 (2019 Plan) Unexercised options / warrants | 441.08K |
2019 Plan - reserved for future issuance Unexercised options / warrants | 3.4M |
2026 Plan - reserved for future issuance Unexercised options / warrants | 11.85M |
Warrant to purchase Series A preferred (to become common upon offering) Unexercised options / warrants | 98.75K |